Abstract:The posttranslational proteolytic cleavage is a unique and irreversible process that governs the function and half-life of numerous proteins. Thereby the role of the family of A disintegrin and metalloproteases (ADAMs) plays a leading part. A member of this family, ADAM8, has gained attention in regulating disorders, such as neurogenerative diseases, immune function and cancer, by attenuating the function of proteins nearby the extracellular membrane leaflet. This process of "ectodomain shedding" can alter the turnover rate of a number of transmembrane proteins that function in cell adhesion and receptor signal transduction. In the past, the major focus of research about ADAMs have been on neurogenerative diseases, such as Alzheimer, however, there seems to be evidence for a connection between ADAM8 and cancer. The role of ADAMs in the field of cancer research has gained recent attention, but it has been not yet been extensively addressed. Thus, this review article highlights the various roles of ADAM8 with particular emphasis on pathological conditions, such as cancer and malignant cancer progression. Here, the shedding function, direct and indirect matrix degradation, effects on cancer cell mobility and transmigration, and the interplay of ADAM8 with matrix-embedded neighboring cells are presented and discussed. Moreover, the most probable mechanical impact of ADAM8 on cancer cells and their matrix environment is addressed and debated. In summary, this review presents recent advances in substrates/ligands and functions of ADAM8 in its new role in cancer and its potential link to cell mechanical properties and discusses matrix mechanics modifying properties. A deeper comprehension of the regulatory mechanisms governing the expression, subcellular localization, and activity of ADAM8 is expected to reveal appropriate drug targets that will permit a more tailored and fine-tuned modification of its proteolytic activity in cancer development and metastasis.

Regulation of ADAM10 activity through microdomain-dependent intracellular calcium changes

Adam10 Promotes Pituitary Adenoma Cell Migration By Regulating Cleavage Of Cd44 And L1

Non-canonical function of ADAM10 in presynaptic plasticity

Alpha-Secretase ADAM10 Regulation: Insights into Alzheimer’s Disease Treatment

An activated form of ADAM10 is tumor selective and regulates cancer stem-like cells and tumor growth

An activated form of ADAM10 is tumor selective and regulates cancer stem-like cells and tumor growthTargeted inhibition of active ADAM10 in tumors

Regulation of Alpha-Secretase ADAM10 In vitro and In vivo: Genetic, Epigenetic, and Protein-Based Mechanisms

A Disintegrin And Metalloprotease 10 expression within the murine central nervous system

The versatile roles of ADAM8 in cancer cell migration, mechanics, and extracellular matrix remodeling

Research advance in the function of a disintegin and metalloprotease 10

Molecular Switch In Human Diseases-Disintegrin And Metalloproteinases, Adam17

TACE activation by MAPK-mediated regulation of cell surface dimerization and TIMP3 association.

The Role of ADAM10 in Alzheimer’s Disease

A disintegrin and metalloproteinase domain 10 expression inhibition by the small molecules adenosine, cordycepin and N6, N6-dimethyladenosine and immune regulation in malignant cancers

ADAM9 inhibition increases membrane activity of ADAM10 and controls α-secretase processing of amyloid precursor protein

ADAM10-a "multitasker" in sepsis: focus on its posttranslational target

ADAM10 Mediates Ectopic Proximal Tubule Development and Renal Fibrosis Through Notch Signalling

Structural Characterization of the Ectodomain of a Disintegrin and Metalloproteinase-22 (ADAM22), a Neural Adhesion Receptor Instead of Metalloproteinase: Insights on ADAM Function.

An Overview of ADAM9: Structure, Activation, and Regulation in Human Diseases

The in vitro activity of ADAM-10 is inhibited by TIMP-1 and TIMP-3

Extracellular Release of a Disintegrin and Metalloproteinase Correlates With Periodontal Disease Severity